See also this year's filing and all EDGAR filings for this company.
PDF Report 0001367832_2014_Aurora_Diagnostics_Holdings_LLC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | No LiabilitiesAndStockholdersEquity node found | input.sec.calculation_linkbase.edgar_model_mapping | {'lase_node': None, 'equity_node': None, 'partners_cap_node': None, 'nodes': "NodeView(('LiabilitiesCurrent', 'LiabilitiesAndMembersEquity', 'LongTermDebtNoncurrent', 'DeferredTaxLiabilitiesNoncurrent', 'BusinessCombinationContingentConsiderationLiabilityNoncurrent', 'OtherLiabilitiesNoncurrent', 'MembersEquity', 'DeferredFinanceCostsNoncurrentNet', 'OtherAssetsNoncurrentTotal', 'DepositsAssetsNoncurrent', 'Goodwill', 'IntangibleAssetsNetExcludingGoodwill', 'AssetsCurrent', 'Assets', 'PropertyPlantAndEquipmentNet', 'CashAndCashEquivalentsAtCarryingValue', 'AccountsReceivableNetCurrent', 'PrepaidExpenseAndOtherAssetsCurrent', 'PrepaidTaxes', 'DeferredTaxAssetsNetCurrent', 'LongTermDebtCurrent', 'BusinessCombinationContingentConsiderationLiabilityCurrent', 'AccountsPayableAndAccruedLiabilitiesCurrent', 'EmployeeRelatedLiabilitiesCurrent', 'InterestPayableCurrent', 'PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest', 'OfferingCostsPartnershipInterests', 'RetainedEarningsAccumulatedDeficit'))"} |
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001367832, Aurora Diagnostics Holdings LLC
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 272,531,000 |
| 1 | AssetsNonCurrent | 0 |
| 2 | AssetsCurrent | 39,511,000 |
| 3 | PropertyPlantAndEquipment | 10,304,000 |
| 4 | remainder_Assets | 6,539,000 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 44,851,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 64,949,000 |
| 11 | GoodwillImpairmentLoss | 53,876,000 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | 169,615,000 |
| 17 | remainder_Revenues | 248,169,000 |
| 18 | remainder_NetIncome | -32,743,000 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 328,885,000 |
| 1 | Liabilities | 44,851,000 |
| 2 | Expenses | 288,440,000 |
| 3 | Revenues | 248,169,000 |
| 4 | StockholdersEquity | 284,034,000 |
| 5 | NetIncome | -73,014,000 |
| 6 | ComprehensiveNetIncome | -73,014,000 |
| 7 | BaseVar | 471,544,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.81 |
| 9 | EconomicCapitalRatio | 2.25 |